Research - Ottawa, Ontario, Canada
GeneRxN research focuses on improving Alzheimer's Disease screening and diagnostics. GeneRxN is not only developing cutting edge technology to rapidly and accurately detect AD risk genes but is also working on a novel blood based screening tool that will revolutionize the diagnostic process for the at-risk population.